Evidence map›Paper›PMID 41484061›Full record

ArticleNutrition & diabetes2026

Relationships between diabetes, vitamin D status, depression, and Hispanic ethnicity: a project FRONTIER study.

Riley McCready, Claudia Morris, Philip Antwi-Adjei, Mohammed Pourghaed, Ashish Sarangi, Annette Boles, Felipe Ramirez-Velandia, Jonathan Kopel, John Culberson, Jonathan Singer and 6 more

Abstract read
In one paragraph

Article in Nutrition & diabetes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Riley McCreadyDepartment of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Claudia MorrisDepartment of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Philip Antwi-AdjeiDepartment of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Mohammed PourghaedDepartment of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Ashish SarangiDepartment of Psychiatry, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Annette BolesGarrison Institute on Aging, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Felipe Ramirez-VelandiaGarrison Institute on Aging, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Jonathan KopelSchool of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
John CulbersonSchool of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.ORCID 0000-0002-1112-5672
Jonathan SingerDepartment of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Gabriela AshworthDepartment of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Marwan N SabbaghDepartment of Neurology, Barrow Neurological Institute, Phoenix, AZ, USA.
Volker NeugebauerDepartment of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Boris DecourtDepartment of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Andrew C ShinCenter of Excellence for Translational Neuroscience and Therapeutics, Texas Tech University Health Sciences Center, Lubbock, TX, USA.ORCID 0000-0002-4748-5135
J Josh LawrenceDepartment of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX, USA. john.lawrence@ttuhsc.edu.ORCID 0000-0002-9068-0841

Funding

The Alzheimer's Clinical Trial Consortium - Down Syndrome Network (ACTC- DSN)U24AG057437 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Paul S. Aisen, RONALD C PETERSEN · 2018 to 2026
$198.4M
Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's DiseaseR01AG053798 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI AISEN, PAUL S., CUMMINGS, JEFFREY L. · 2017 to 2022
$39.4M
Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - ResubmissionP20GM109025 · NIGMS · CLEVELAND CLINIC FOUNDATION · PI Robert J. Fox, Jefferson Kinney · 2015 to 2026
$22.8M
Psychosocial Approaches to Better Understanding & End-Stage Cancer Care (PROTECT)R35CA197730 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI Holly Gwen Prigerson · 2015 to 2026
$11.2M
MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI PatientsR01AG059008 · NIA · ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER · PI DECOURT, BORIS, SABBAGH, MARWAN NOEL · 2018 to 2023
$3.6M
NVEDARC Clinical CoreP20AG068053 · NIA · CLEVELAND CLINIC FOUNDATION · PI FOX, ROBERT J. · 2020 to 2022
$3.3M
The hippocampal dentate gyrus in aging and Alzheimer's disease: boosting transcription of retinoic acid-sensitive genes through vitamin A supplementation and HDAC inhibitionR01AG073826 · NIA · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI John Joshua Lawrence · 2022 to 2026
$3.1M
Repurposing Siponimod for Alzheimer's DiseaseR01AG073212 · NIA · ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER · PI Boris Decourt, MARWAN Noel SABBAGH · 2021 to 2026
$2.8M
Transcriptional Dysfunction in Dentate Gyrus Cell Types: Roles of Retinoic Acid Responsive Genes in Protection Against Alzheimer's Disease PathogenesisR01AG071859 · NIA · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI John Joshua Lawrence · 2022 to 2026
$1.9M
Reducing suicide risk among aging caregivers of persons with AD/ADRD: Adapting, implementing, and evaluating Dialectical Behavior Therapy skills training interventions.R15AG080446 · NIA · TEXAS TECH UNIVERSITY · PI MITCHELL, SEAN M, SINGER, JONATHAN · 2023 to 2023
$459k
Alzheimer's Drug Discovery Foundation (ADDF) GC-2013717NCI NIH HHS R35 CA197730NIA NIH HHS P20 AG068053NIA NIH HHS R01 AG053798NIA NIH HHS R01 AG059008NIA NIH HHS R01 AG071859NIA NIH HHS R01 AG073212NIA NIH HHS R01 AG073826NIA NIH HHS R15 AG080446NIA NIH HHS U24 AG057437NIGMS NIH HHS P20 GM109025U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R35CA197730U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) P20GM109025U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) P20AG068053U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) R01AG053798U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) R01AG059008U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) R01AG071859U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) R01AG073212U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) R01AG073826U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) R15AG080446U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) U24AG057437
6 · The paper itself

Abstract

BACKGROUND/

objectivesVitamin D (VD) status has been linked to the development of diabetes. However, this relationship in the context of comorbid conditions remains understudied. Additionally, ethnic disparities in nutritional status and chronic disease prevalence within rural populations are a vastly underrepresented area of research. In our previous study, we explored VD levels and depression in a rural West Texas aging sample. In the present study, we investigated the associations between diabetes, vitamin D (VD) levels, depression, and Hispanic ethnicity (HE) among a sample of aging, rural West Texans from Project FRONTIER (PF; Facing Rural Obstacles to Health Care Now Through Intervention, Education, and Research). SUBJECTS/

methodsA cohort of 299 PF participants (mean age 62.6 ± 11.8 years old, 70.9% female, 40.5% HE) was used. We examined relationships between diabetes diagnosis, blood-based diabetes-related biomarkers, VD level, Geriatric Depression Scale (GDS) score, and HE status. We developed a "VD-sensitive GDS score" composed of the 9 GDS questions that were significantly correlated with VD level in our previous study. We further created a complementary "VD-insensitive GDS score" composed of the remaining 21 GDS questions. Standard correlation and regression analyses were employed.

resultsVD level was significantly negatively associated with diabetes diagnosis, while VD-sensitive depression score was significantly positively associated with diabetes diagnosis. HE was associated with higher HbA1c levels, higher fasting blood glucose levels, and higher VD-sensitive depression scores.

conclusionsIn this rural West Texas cohort, diabetes was significantly associated with low VD levels and high VD-sensitive depression scores. HE was associated with higher levels of diabetes-related biomarkers and higher VD-sensitive depression scores. These disparities are crucial to consider when examining areas for healthcare improvement in West Texas, particularly among aging populations.

Indexed as

DepressionDiabetes MellitusHispanic or LatinoVitamin DVitamin D DeficiencyAgedBiomarkersCohort StudiesFemaleGlycated HemoglobinHumansMaleMiddle AgedNutritional StatusRural PopulationTexasBiomarkersGlycated HemoglobinVitamin D

Identifiers

PMID41484061
PMCPMC12770327

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.